简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-12-07 14:08 Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling
2021-12-06 19:31 Galderma Announces New Data Demonstrating the Positive Anti-inflammatory Effect and Mode of Action of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
2021-12-06 11:42 Bluehole Publishes a Feature Story on China’s Recent Vaping Regulations
2021-12-06 11:37 Healthcare+ Expo Taiwan to Build an Ecosystem of Digital Transformation in Healthcare
2021-12-03 16:45 CHG Healthcare Switches to Rimini Street to Achieve Better System Availability, Smoother Operation and Enhanced Outcomes for 25 Million Patients Annually
2021-12-03 14:25 Seoul Viosys Provides Air Purifier Sterilizers, Which Dramatically Reduce the Risk of COVID-19 Infection, to 300 Small Businesses in Korea for Free
2021-12-03 11:43 Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
2021-12-03 09:22 Vifor Pharma comments on market speculations
2021-12-01 19:00 Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India
2021-12-01 18:52 ITabMed Completes Series A-round Financing after Spin-off
2021-12-01 13:57 Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea
2021-11-30 20:13 New World Group’s Humansa Announces Anchor Partnership with Key Medical Institutions in the Greater Bay Area to Reinvent Personalised and Holistic Consumer Healthcare Services
2021-11-30 15:22 Aster Guardians Global Nursing Award Worth US $250,000 Now Open for Nominations From Nurses Worldwide
2021-11-30 14:15 Vifor Pharma announces changes to the Executive Committee as CFO retires
2021-11-30 09:26 Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients
2021-11-26 14:22 Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis
2021-11-25 18:31 MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a.
2021-11-24 15:35 Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
2021-11-24 09:47 Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies
2021-11-22 16:22 Merck Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus

Business Wire Weibo

Press Releases

Latest Releases